"10.1371_journal.pone.0114569","plos one","2014-12-26T00:00:00Z","Kathrin Malejko; Patrick Weydt; Sigurd D Süßmuth; Georg Grön; Bernhard G Landwehrmeyer; Birgit Abler","Department of Psychiatry, Ulm University, Leimgrubenweg 12–14, 89522, Ulm, Germany; Department of Neurology, Ulm University, Oberer Eselsberg 45, 89081, Ulm, Germany","Conceived and designed the experiments: KM PW BA. Performed the experiments: KM PW BA. Analyzed the data: KM GG BA. Wrote the paper: KM PW BA. Patient Recruitment: SDS BGL.","K.M., P.W., G.G. and B.A. report no disclosures. S.D.S has received funding for travel from Ipsen and Novartis and received honoraria for lectures from Commonwealth SerumLaboratories (CSL) Behring and Bayer. B.G.L. has received consulting fees from Siena Biotech, Aop-Orphan pharmaceuticals, Teva Pharmaceutical Industries, GlaxoSmithKline, Bayer Pharma Aktiengesellschaft (AG), Ipsen Pharma and research support from the European Commission, Cure Huntington Disease Initiative (CHDI) Foundation, Medivation, NeuroSearch, Novartis, Medesis Pharma and Amarin Pharma. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2014","12","Kathrin Malejko","KM",6,TRUE,3,3,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
